Prevalence of multi and pan drug resistant Pseudomonas aeruginosa with respect to ESBL and MBL in a tertiary care hospital

Indian Journal of Pathology and Microbiology

Volumn 50, Issue 4, 2007, Pages 922-925

  Jayakumar, S ^a   Appalaraju, B ^a  

^a PSG INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

Extended spectrum lactamase (ESBL); Metallo lactamase (MBL); Multi drug resistant Pseudomonas aeruginosa (MDRPA); Pan drug resistant Pseudomonas aeruginosa (PDRPA)

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BACTERIAL ENZYME; CEFEPIME; CEFOTAXIME; CEPHALOSPORINASE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ENZYME SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS; HUMANS; IMIPENEM; INDIA; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; THIENAMYCINS;

EID: 37349027279     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Karlowsky AJ, Draghi CD, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for Antimicrobial Susceptibility among Clinilcal Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001. Antimicrob Agents Chemother2003; 47: 1681-8.
2. Wang CY, Jerng JS, Cheng KY, et al. Pandrug -resistant Pseudomonas aeruginosa among hospitalized patients: clinical features, risk- factors and outcomes. Clin Microbiol Infec2006; 12: 63-68.
3. Flavia L, Lucia MT, Maria GSC, Simone AN, et al. Occurrence of a Multidrug- Resistant Pseudomonas aeruginosa Clone in Different Hospitals in Rio de Janerio, Brazil. J Clin Microbiol 2002; 40:2420-4.
4. th ed. Philadelphia:Lippincott ,1997:253.
5. th ed. Approved Standards NCCLS document M2-A7, Wayne, PA: National Committee for Clinical Laboratory Standards; 2001.
6. Lee K, Lim YS, Yong D, Yum JM, Chong Y. Evaluation of the Hodge test and Imipenem-EDTA Double-disk synergy test for Differentiating Metallo-b Lactamase-Producing Isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol2003; 41:4623-9.
7. Mandal A. Broth Dilution Test. In: Antimicrobials in Laboratory Medicine. Rattan A ed.B.I. Churchill Livingstone Pvt Ltd, 2000: 85.
8. Obritsch MD, Fish DN, MacLaren R, Jung R. National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates obtained from Intensive Care Unit patients from 1993 to 2002. Antimicrob Agents Chemother2004; 48:4606-10.
9. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterisation of Pseudomonas aeruginosa isolates: Occurrence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis2001; 32 (SUPPL 2):S146-55.
10. Flamm RK, Weaver MK, Thornsbery C, Jones ME, Karlowky JA, Sahm DF. Factors Associated with Relative Rates of Antibiotic Resistance in Pseudomonas aeruginosa Isolates tested in Clinical laboratories in the US from 1999 to 2002. Antimicob Agents Chemother2004; 48:2431-6.
11. Mehta M, Punia JN, Joshi RM. Antibiotic resistance in Pseudomonas aeruginosa strains isolated from various clinical specimens- A retrospective study. Indian J Med Microbiol2001; 19:232.
12. th ed. Vol 2.Elsevier Churchill Livingstone, 2005:2587.
13. th ed.ASM Press Washington DC, 2003:749.
14. Singhal S, Mathur T, Khan S,et al. Evaluation of Methods For AmpC β - lactamase in Gram negative clinical isolates from tertiary care hosipitals. Indian J Med Microbiol 2005; 23:120-4.
15. Marry VJ, Kandathil AJ, Balaji V. Comparison of two methods to detect carbapenemase and metallo β-lactamase production in clinical isolates. Indian J Med Res2005; 121:780-3.
16. Livermore DM. Leading article of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother2001; 47:247-50.